TAKEDA PHARMACEUTICA | TalkMarkets

Latest Posts

Current Analysis: Takeda Pharmaceutical

Article By: Fredrik Arnold

Tuesday, April 9, 2024 8:55 PM EDT

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. Over the past year, Takeda’s share price fell 20.5% from $34.04 to $27.05 as of Tuesday’s market close.

In this article: TKPHF

Read

Current Analysis: Takeda Pharmaceuticals (TKPHF)

Article By: Fredrik Arnold

Sunday, November 12, 2023 9:34 PM EDT

TKPHF is the largest Japanese drug company. Furthermore the estimated $45.50 dividend income from $1k invested is about 1.64 times greater than Friday’s price of a single share

In this article: TKPHF

Read

Asia-Pacific Region Will Continue To Dominate M&A Activity In 2H2018

Article By: AllAboutAlpha

Thursday, August 23, 2018 3:30 AM EDT

The issue of post-merger integration (PMI) is no longer considered to be a world distinct from the matter of the initial acquisition itself.

In this article: TKPHF Also: SHPG

Read

Takeda Pharmaceutical Company Continues Global R&D Reboot, Enters JV With PRA Health

Article By: Lorimer Wilson

Friday, April 7, 2017 7:48 PM EDT

PRA Health Sciences (NASDAQ:PRAH) has entered into a joint venture with Takeda Pharmaceutical Company Limited to further globalize Takeda’s development business in Japan.

In this article: PRAH, TKPHF

Read